After the 9/11 attacks, the United States considered immunizing the entire population to protect against a terrorist attack with smallpox. “In the end, it was decided not, because of the negative consequences of vaccinating so many people,” said Bill Hanage, an epidemiologist at Harvard T.H. Chan School of Public Health.
“Side effects of the vaccine are rare,” he added. “But once you start giving it to millions of people, they’re going to start collecting.”
New generation vaccines Like Jynneos it is likely to be safer for large groups, and a circular vaccination may be sufficient to contain the virus. “Hopefully, monkeypox is likely to be relatively rare at the moment, and a loop-vaccination strategy might be able to drive it away completely,” Dr. Hanage said.
In addition to preventive vaccines, the United States has purchased more than two million doses of an antiviral pill called tekovirimat, which is agreed To treat chickenpox in infected people, according to the Centers for Disease Control and Prevention, the agency is also working with the drug’s manufacturer to develop an intravenous form.
Human monkeypox was first identified in 1970 in a 9-year-old boy in an area of the Democratic Republic of the Congo where smallpox has been eradicated. Monkeypox cases in the country have A significant increase In the decades since the end of mass vaccination against smallpox.
In 2003, the United States recorded dozens of monkeypox cases that were traced back to infected pets. Although the virus was first discovered in 1958 in monkeys kept for research purposes, it is spread by rodents.
One to two weeks after exposure, those infected may begin to have a fever, sore throat, cough, fatigue, and body aches. They also have a characteristic rash, first on the face, then on the palms and soles of the feet, and then all over the body. The lesions ulcerate, grow, and fill with a white, pus-like substance.